Thus, based on the proof of targeting SR-B1, HDL particles may effectively aggregate to the tumor site, and enhance the cell uptake of drugs, leading to an increased anti-tumor effect and reverse drug resistance. This evidence concerns the gene SCARB1 and neoplasm.